ClinConnect ClinConnect Logo
Search / Trial NCT06526637

User Testing of an End of Life Medication Support Intervention for Lay Carers (Palliate).

Launched by IMPERIAL COLLEGE LONDON · Jul 25, 2024

Trial Information

Current as of July 01, 2025

Not yet recruiting

Keywords

Palliative Care

ClinConnect Summary

This clinical trial, called Palliate, is focused on improving support for family members who care for loved ones at the end of life. The study aims to evaluate how well a new nurse-led program works in helping these caregivers administer necessary medications at home. This program includes training and helpful materials designed to make it easier and safer for family caregivers to provide care during this challenging time. The intervention has already been tested successfully in parts of London and is now being studied further to ensure its effectiveness and acceptability.

To participate in this trial, individuals must be 18 years or older and able to communicate in English. Unfortunately, those under 18 or who cannot communicate in English will not be eligible. Participants can expect to engage in a process that supports them in caring for their loved ones, with guidance from trained nurses. As the trial is not yet recruiting, further details on how to join will be provided when it begins.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Individuals aged 18 years or older and able to communicate in English.
  • Exclusion Criteria:
  • Individuals aged less than 18 years old and/or unable to communicate in English.

About Imperial College London

Imperial College London is a world-renowned research institution based in the United Kingdom, recognized for its commitment to advancing medical science and improving patient care through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, Imperial combines expertise across various fields, including medicine, engineering, and business, to drive breakthroughs in healthcare. The institution’s robust clinical trial programs are designed to evaluate new therapies and interventions, ensuring rigorous scientific standards and ethical practices while aiming to translate research findings into tangible benefits for patients and society.

Locations

London, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Leila Shepherd, PhD

Principal Investigator

Imperial College London

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported